DNA methylation and Alzheimer's disease

Epigenetics of Aging

Volumn , Issue , 2010, Pages 315-326

  Van Groen, Thomas ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Alzheimer's disease; APP; Beta secretase; Epigenetics; Gamma secretase

Indexed keywords

EID: 84888198610     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-0639-7_17     Document Type: Chapter

References (86)

1. Basha, M. R., Murali, M., Siddiqi, H. K., Ghosal, K., Siddiqi, O. K., Lashuel, H. A., Ge, Y. W., Lahiri, D. K., and Zawia, N. H. 2005. Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation. FASEB J. 19:2083-2084.
2. Bassett, S. S., Avramopoulos, D., and Fallin, D. 2002. Evidence for parent of origin effect in lateonset Alzheimer disease. Am J Med Genet. 114:679-686.
3. Bassett, S. S., Avramopoulos, D., Perry, R. T., Wiener, H., Watson, B. Jr., Go, R. C., and Fallin, M. D. 2006. Further evidence of a maternal parent-of-origin effect on chromosome 10 in late-onset Alzheimer's disease. Am J Med Genet. 141B:537-540.
4. Berger, J., and Bird, A. 2005. Role of MBD2 in gene regulation and tumorigenesis. Biochem Soc Trans. 33(Pt 6):1537-1540.
5. Bestor, T. H. 2000. The DNA methyltransferases of mammals. Hum Mol Genet. 9:2395-2402.
6. Beyreuther, K., Pollwein, P., Multhaup, G., Mönning, U., König, G., Dyrks, T., Schubert, W., and Masters, C. L. 1993. Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome. Ann NY Acad Sci. 695:91-102.
7. Bjornsson, H. T., Sigurdsson, M. I., Fallin, M. D., Irizarry, R. A., Aspelund, T., Cui, H., Yu, W., Rongione, M. A., Ekström, T. J., Harris, T. B., Launer, L. J., Eiriksdottir, G., Leppert, M. F., Sapienza, C., Gudnason, V., and Feinberg, A. P. 2008. Intra-individual change over time in DNA methylation with familial clustering. JAMA. 299:2877-2883.
8. Braak, H., Braak, E. 1993. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:239-259.
9. Braak, H., Braak, E. 1998. Evolution of neuronal changes in the course of Alzheimer's disease. J. Neural. Transm. 53:127-140.
10. Cabrejo, L., Guyant-Maréchal, L., Laquerrière, A., Vercelletto, M., De la Fournière, F., Thomas- Antérion, C., Verny, C., Letournel, F., Pasquier, F., Vital, A., Checler, F., Frebourg, T., Campion, D., and Hannequin, D. 2006. Phenotype associated with APP duplication in five families. Brain. 129:2966-2976.
11. Cao, X., and Südhof, T. C. 2004. Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J Biol Chem. 279:24601-24611.
12. Cheng, X., and Blumenthal, R. M. 2008. Mammalian DNA methyltransferases: a structural perspective. Structure. 16:341-350.
13. Davis, C. D., and Uthus, E. O. 2003. Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt formation, global DNA methylation and one-carbon metabolism in rats. J Nutr. 133:2907-2914.
14. Del Parigi, A., Panza, F., Capurso, C., and Solfrizzi, V. 2006. Nutritional factors, cognitive decline, and dementia. Brain Res Bull. 69:1-19.
15. Detich, N., Theberge, J., and Szyf, M. 2002. Promoter-specific activation and demethylation by MBD2/demethylase. J Biol Chem. 277:35791-35794.
16. Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., and Verhoef, P. 2007. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet. 369:208-216.
17. Fortini, M. E. 2002. Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat Rev Mol Cell Biol. 3:673-684.
18. Fuso, A., Seminara, L., Cavallaro, R. A., D'Anselmi, F., and Scarpa, S. 2005. Sadenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol Cell Neurosci. 28:195-204.
19. Fuso, A., Cavallaro, R. A., Zampelli, A., D'Anselmi, F., Piscopo, P., Confaloni, A., and Scarpa, S. 2007. gamma-Secretase is differentially modulated by alterations of homocysteine cycle in neuroblastoma and glioblastoma cells. J Alzheimer's Dis. 11:275-290.
20. Gao, S., Hendrie, H. C., Hall, K. S., and Hui, S. 1998. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry. 55: 809-815.
21. Gillette Guyonnet, S., Abellan Van Kan, G., Andrieu, S., Barberger Gateau, P., Berr, C., Bonnefoy, M., Dartigues, J. F., de Groot, L., Ferry, M., Galan, P., Hercberg, S., Jeandel, C., Morris, M. C., Nourhashemi, F., Payette, H., Poulain, J. P., Portet, F., Roussel, A. M., Ritz, P., Rolland, Y., and Vellas, B. 2007. IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging. 11:132-52.
22. Gordon, N. 1997. Nutrition and cognitive function. Brain Dev. 19:165-170.
23. Haan, M. N., Miller, J. W., Aiello, A. E., Whitmer, R. A., Jagust, W. J., Mungas, D. M., Allen, L. H., and Green, R. 2007. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr. 85:511-517.
24. Hamm, S., Just, G., Lacoste, N., Moitessier, N., Szyf, M., and Mamer, O. 2008. On the mechanism of demethylation of 5-methylcytosine in DNA. Bioorg Med Chem Lett. 18:1046-1049.
25. Hardy, J. 2006. Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. J Alzheimers Dis. 9(3 Suppl):151-153.
26. Hardy, J. A., and Higgins, G. A. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science. 256:184-185.
27. Hartmann, T., Kuchenbecker, J., and Grimm, M. O. 2007. Alzheimer's disease: the lipid connection. J Neurochem. 103(1 Suppl):159-170.
28. Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., and Evans, D. A. 2003. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 60: 1119-1122.
29. Hébert, S. S., Serneels, L., Tolia, A., Craessaerts, K., Derks, C., Filippov, M. A., Müller, U., and De Strooper, B. 2006. Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes. EMBO Rep. 7:739-745.
30. Hirtz, D., Thurman, D. J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A. R., and Zalutsky, R. 2007. How common are the "common" neurologic disorders? Neurology. 68:326-337.
31. Hyman, B. T., Augustinack, J. C., and Ingelsson, M. 2005. Transcriptional and conformational changes of the tau molecule in Alzheimer's disease. Biochim Biophys Acta. 1739: 150-157.
32. Jaenisch, R., and Bird, A. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 33 (Suppl):245-254.
33. Jeltsch, A., Nellen, W., and Lyko, F. 2006. Two substrates are better than one: dual specificities for Dnmt2 methyltransferases. Trends Biochem Sci. 31:306-308.
34. Kaether, C., Schmitt, S., Willem, M., and Haass, C. 2006. APP and Notch intracellular domains are generated after transport of their precursors to the cell surface. Traffic. 7:408-415.
35. Kaminsky, Z., Wang, S. C., and Petronis, A. 2006. Complex disease, gender and epigenetics. Ann Med. 38:530-544.
36. Klose, R. J., and Bird, A. P. 2006. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 31:89-97.
37. Lahiri, D. K., Maloney, B., Basha, M. R., Ge, Y. W., and Zawia, N. H. 2007. How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD. Curr Alzheimer Res. 4:219-228.
38. Ledoux, S., Rebai, N., Dagenais, A., Shaw, I. T., Nalbantoglu, J., Sekaly, R. P., and Cashman, N. R. 1993. Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation. J Immunol. 150:5566-5575.
39. Ledoux, S., Nalbantoglu, J., and Cashman, N. R. 1994. Amyloid precursor protein gene expression in neural cell lines: influence of DNA cytosine methylation. Mol Brain Res. 24: 140-144.
40. Li, E., Bestor, T. H., and Jaenisch, R. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 69:915-926.
41. Liu, L., van Groen, T., Kadish, I., and Tollefsbol, T. O. 2007. DNA methylation impacts on learning and memory in aging. Neurobiol Aging. Epub Sep 10.
42. Lopatina, N., Haskell, J. F., Andrews, L. G., Poole, J. C., Saldanha, S., and Tollefsbol, T. 2002. Differential maintenance and de novo methylating activity by three DNA methyltransferases in aging and immortalized fibroblasts. J Cell Biochem. 84:324-334.
43. Luchsinger, J. A., and Mayeux, R. 2004. Dietary factors and Alzheimer's disease. Lancet Neurol. 3:579-587.
44. Luchsinger, J. A., Tang, M. X., Miller, J., Green, R., Mehta, P. D., and Mayeux, R. 2007a. Relation of plasma homocysteine to plasma amyloid beta levels. Neurochem Res. 32:775-781.
45. Luchsinger, J. A., Tang, M. X., Miller, J., Green, R., and Mayeux, R. 2007b. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol. 64:86-92.
46. Luchsinger, J. A., Noble, J. M., and Scarmeas, N. 2007c. Diet and Alzheimer's disease. Curr Neurol Neurosci Rep. 7:366-372.
47. Luedi, P. P., Hartemink, A. J., and Jirtle, R. L. 2005. Genome-wide prediction of imprinted murine genes. Genome Res. 15:875-884.
48. Mani, S. T., and Thakur, M. K. 2006. In the cerebral cortex of female and male mice, amyloid precursor protein (APP) promoter methylation is higher in females and differentially regulated by sex steroids. Brain Res. 1067:43-47.
49. Mosconi, L., Brys, M., Switalski, R., Mistur, R., Glodzik, L., Pirraglia, E., Tsui, W., De Santi, S., and de Leon, M.J. 2007. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci USA. 104(48):19067-19072.
50. Müller, T., Concannon, C. G., Ward, M. W., Walsh, C. M., Tirniceriu, A. L., Tribl, F., Kögel, D., Prehn, J.H., and Egensperger, R. 2007. Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol Biol Cell. 18: 201-210.
51. Müller, T., Meyer, H. E., Egensperger, R., and Marcus, K. 2008. The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-Relevance for Alzheimer's disease. Prog Neurobiol. Epub Jul 5.
52. Nguyen, S., Meletis, K., Fu, D., Jhaveri, S., and Jaenisch, R. 2007. Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan. Dev Dyn. 236:1663-1676.
53. Niculescu, M. D., Craciunescu, C. N., and Zeisel, S. H. 2006. Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains. FASEB J. 20:43-49.
54. Pallàs, M., and Camins, A. 2006. Molecular and biochemical features in Alzheimer's disease. Curr Pharm Des. 12:4389-4408.
55. Peters, J., and Beechey, C. 2004. Identification and characterisation of imprinted genes in the mouse. Brief Funct Genomic Proteomic. 2:320-333.
56. Pollwein, P., Masters, C. L., and Beyreuther, K. 1992. The expression of the amyloid precursor protein (APP) is regulated by two GC-elements in the promoter. Nucleic Acids Res. 20:63-68.
57. Querfurth, H. W., Jiang, J., Xia, W., and Selkoe, D. J. 1999. Enhancer function and novel DNA binding protein activity in the near upstream betaAPP gene promoter. Gene. 232:125-141.
58. Qiu, C., De Ronchi, D., and Fratiglioni, L. 2007. The epidemiology of the dementias: an update. Curr Opin Psychiatry. 20:380-385.
59. Robert, L. 2004. Epigenetic post-transcriptional mechanisms for regulating physiological functions, and their decline during aging. J Soc Biol. 198:257-262.
60. Rogaev, E. I., Lukiw, W. J., Lavrushina, O., Rogaeva, E. A., and St George-Hyslop, P. H. 1994. The upstream promoter of the beta-amyloid precursor protein gene (APP) shows differential patterns of methylation in human brain. Genomics. 22:340-347.
61. Rovelet-Lecrux, A., Hannequin, D., Raux, G., LeMeur, N., Laquerrière, A., Vital, A., Dumanchin, C., Feuillette, S., Brice, A., Vercelletto, M., Dubas, F., Frebourg, T., and Campion, D. 2006. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet. 38:24-26.
62. Salbaum, J. M., Weidemann, A., Lemaire, H. G., Masters, C. L., and Beyreuther, K. 1988. The promoter of Alzheimer's disease amyloid A4 precursor gene. EMBO J. 7:2807-2813.
63. Scarpa, S., Cavallaro, R. A., D'Anselmi, F., and Fuso, A. 2006. Gene silencing through methylation: an epigenetic intervention on Alzheimer disease. J Alzheimers Dis. 9:407-414.
64. Schäfer, S., Wirths, O., Multhaup, G., and Bayer, T. A. 2007. Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease. J Neural Transm. 114:387-394.
65. Schupf, N., and Sergievsky, G. H. 2002. Genetic and host factors for dementia in Down's syndrome. Br J Psychiatry. 180:405-410.
66. Selkoe, D. J. 2001. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 81:741-766.
67. Selkoe, D., and Kopan, R. 2003. Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci. 26:565-597.
68. Selkoe, D. J., and Wolfe, M. S. 2007. Presenilin: running with scissors in the membrane. Cell. 131:215-221.
69. Sibani, S., Melnyk, S., Pogribny, I. P., Wang, W., Hiou-Tim, F., Deng, L., Trasler, J., James, S. J., and Rozen, R. 2002. Studies of methionine cycle intermediates (SAM, SAH), DNA methylation and the impact of folate deficiency on tumor numbers in Min mice. Carcinogenesis. 23:61-65.
70. Singhal, R. P., Mays-Hoopes, L. L., and Eichhorn, G. L. 1987. DNA methylation in aging of mice. Mech Ageing Dev. 41:199-210.
71. Snowdon, D. A., Tully, C. L., Smith, C. D., Riley, K. P., and Markesbery, W. R. 2000. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am J Clin Nutr. 71:993-998.
72. Swerdlow, R. H. 2007. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Neurobiol Aging. 28:1465-1480.
73. Tanzi, R. E., and Bertram, L. 2005. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell. 120(4):545-555.
74. Tchantchou, F., Graves, M., Ortiz, D., Chan, A., Rogers, E., and Shea, T. B. 2006. S-adenosyl methionine: A connection between nutritional and genetic risk factors for neurodegeneration in Alzheimer's disease. J Nutr Health Aging. 10:541-544.
75. Thakur, M. K., and Mani, S. T. 2005. Estradiol regulates APP mRNA alternative splicing in the mice brain cortex. Neurosci Lett. 381:154-157.
76. Theuns, J., Brouwers, N., Engelborghs, S., Sleegers, K., Bogaerts, V., Corsmit, E., De Pooter, T., van Duijn, C. M., De Deyn, P. P., and Van Broeckhoven, C. 2006. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am J Hum Genet. 78:936-946.
77. Tohgi, H., Utsugisawa, K., Nagane, Y., Yoshimura, M., Genda, Y., and Ukitsu, M. 1999. Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex. Mol Brain Res. 70:288-292.
78. Trasler, J., Deng, L., Melnyk, S., Pogribny, I., Hiou-Tim, F., Sibani, S., Oakes, C., Li, E., James, S. J., and Rozen, R. 2003. Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice. Carcinogenesis. 24:39-45.
79. Van Broeck, B., Van Broeckhoven, C., and Kumar-Singh, S. 2007. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches. Neurodegener. Dis. 4:349-365.
80. Wang, J., Tanila, H., Puoliväli, J., Kadish, I., and van Groen, T. 2003. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice. Neurobiol Dis. 14:318-327.
81. Wang, S. C., Oelze, B., and Schumacher, A. 2008. Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS ONE. 3(7):e2698.
82. West, R. L., Lee, J. M., and Maroun, L. E. 1995. Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patient. J Mol Neurosci. 6:141-146.
83. Wilson, V. L., Smith, R. A., Ma, S., and Cutler, R. G. 1987. Genomic 5-methyldeoxycytidine decreases with age. J Biol Chem. 262:9948-9951.
84. Wolfe, M.S. 2006. The gamma-secretase complex: membrane-embedded proteolytic ensemble. Biochemistry. 45:7931-7939.
85. Wolters, M., Ströhle, A., and Hahn, A. 2004. Age-associated changes in the metabolism of vitamin B(12) and folic acid: prevalence, aetiopathogenesis and pathophysiological consequences. Z Gerontol Geriatr. 37:109-135.
86. Wu, J., Basha, M. R., and Zawia, N. H. 2008. The environment, epigenetics and amyloidogenesis. J Mol Neurosci. 34:1-7.